| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GOOD FELLOW HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 30.09. | GF HEALTHCARE (08143): FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 22.09. | GF HEALTHCARE (08143): COMPANY INFORMATION SHEET | - | HKEx | ||
| 22.09. | GF HEALTHCARE (08143): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.09. | GF HEALTHCARE (08143): CAPITAL REORGANISATION BECOMING EFFECTIVE AND ARRANGEMENT ON ODD LOT TRADING AND ADJUSTMENTS TO THE SHARE OPTION SCHEME | - | HKEx | ||
| 14.09. | GF HEALTHCARE (08143): REVISED TIMETABLE IN RELATION TO PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION ... | - | HKEx | ||
| 09.09. | GF HEALTHCARE (08143): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 9 SEPTEMBER 2026 | - | HKEx | ||
| 04.09. | GF HEALTHCARE (08143): FURTHER DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 07.08. | GF HEALTHCARE (08143): DELAY IN DESPATCH OF CIRCULAR FOR MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): FORM OF PROXY FOR ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): (1) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED ... | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025/2026 | - | HKEx | ||
| 23.07. | GF HEALTHCARE (08143): ANNUAL REPORT 2025/2026 | 2 | HKEx | ||
| 14.07. | GF HEALTHCARE (08143): UPDATE ON PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION OF UNISSUED SHARES | - | HKEx | ||
| 08.07. | GF HEALTHCARE (08143): CLARIFICATION ANNOUNCEMENT MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 30.06. | GF HEALTHCARE (08143): MAJOR TRANSACTION IN RELATION TO ACQUISITION OF INTERESTS IN LIMITED PARTNERSHIP | - | HKEx | ||
| 26.06. | GF HEALTHCARE (08143): REVISED TIMETABLE IN RELATION TO PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION ... | 1 | HKEx | ||
| 22.06. | GF HEALTHCARE (08143): UPDATE ON PROPOSED SHARE CONSOLIDATION AND PROPOSED CAPITAL REDUCTION OF ISSUED SHARES AND SUB-DIVISION OF UNISSUED SHARES | - | HKEx |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 37,500 | +2,12 % | Fresenius Medical Care: Plötzlicher Führungswechsel schürt Zweifel an Zukunft - Kurs bricht weiter ein | Der überraschende Führungswechsel bei Fresenius Medical Care lässt die Aktie abstürzen und schürt Spekulationen über einen radikalen Kurswechsel im angeschlagenen Dialysegeschäft. Anleger und Analysten... ► Artikel lesen | |
| FRESENIUS | 42,355 | +1,84 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,545 | 0,00 % | Morning Market Movers: Veea, NFT Limited, WISeSat.Space, Alignment Healthcare See Big Swings | NEW YORK CITY (dpa-AFX) - At 8:15 a.m. ET on Friday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,140 | +2,30 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,75 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| GENEDX | 67,33 | -0,59 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| CARL ZEISS MEDITEC | 32,420 | +4,38 % | 200-Tage-Linie hält: Goldman verpasst Zeiss Meditec einen Dämpfer | Goldman Sachs stuft Carl Zeiss Meditec auf "Sell" ab und senkt das Kursziel auf 23 Euro. Zwischenzeitlich verlor das Papier gut sieben Prozent, fing sich dann aber knapp über der 200-Tage-Linie. Die... ► Artikel lesen | |
| STARLING ONCOLOGY INSTITUTE | 6,630 | +7,28 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| HEARTFLOW | 49,730 | +4,41 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| DRAEGERWERK | 116,60 | +4,67 % | Draegerwerk AG & Co. KGaA: Sechsjähriger FDA-Belastungsfaktor beseitigt; US-Monitoring-Geschäft rückt wieder in den Fokus; KAUFEN | Dräger hat ein sechs Jahre währendes regulatorisches Kapitel im US-Patientenmonitoring endlich abgeschlossen. Nach der FDA-Freigabe (Clearance) von Dräger IACS VG8.1 hat die Behörde den 2020 ausgesprochenen... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| LIFESTANCE HEALTH GROUP | 12,435 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BILLIONTOONE | 98,14 | +2,86 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 27,940 | +0,40 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| KESTRA MEDICAL TECHNOLOGIES | 26,980 | +4,70 % | Piper Sandler reiterates Kestra Medical stock rating on patent potential |